This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The primary objective of this study is to determine whether interleukin-2 (IL-2) can be of additive benefit in the treatment of chronic hepatitis due to Hepatitis C Virus (HCV). Secondary objectives are to evaluate the immune response to HCV in the presence of IL-2 therapy.
Showing the most recent 10 out of 370 publications